|
1.Shamloo, et al., Death-associated protein kinase is activated by dephosphorylation in response to cerebral ischemia. Journal of Biological Chemistry , 2005. 280(51):42290-42299. DOI: 10.1074/jbc.M505804200. 2.Schneider-Stock, et al., DAPK1 (death-associated protein kinase 1). Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2010. 14(1):7-10. DOI: 10.4267/2042/44654 3.Shohat, et al., The pro-apoptotic function of death-associated protein kinase is controlled by a unique inhibitory autophosphorylation-based mechanism. Journal of Biological Chemistry, 2001. 276(50):47460-47467. DOI: 10.1074/jbc.M105133200. 4.Widau, et al., Protein phosphatase 2A (PP2A) holoenzymes regulate death-associated protein kinase (DAPK) in ceramide-induced anoikis. Journal of Biological Chemistry, 2010. 285(18):13827-13838. DOI: 10.1074/jbc.M109.085076. 5.Anjum, et al., The tumor suppressor DAP Kinase is a target of RSK-mediated survival signaling. Current Biology, 2005. 15(19):1762-1767. DOI: 10.1016/j.cub.2005.08.050. 6.Chen, et al., Bidirectional signals transduced by DAPK–ERK interaction promote the apoptotic effect of DAPK. The EMBO Journal, 2005. 24(2):294-304. DOI: 10.1038/sj.emboj.7600510. 7.Wang, et al., The tumor suppressor DAPK is reciprocally regulated by tyrosine kinase Src and phosphatase LAR. Molecular Cell, 2007. 27(5):701-716. DOI: 10.1016/j.molcel.2007.06.037. 8.Shang, et al., Death-associated protein kinase as a sensor of mitochondrial membrane potential. Journal of Biological Chemistry, 2005. 280(41):34644-34653. DOI: 10.1074/jbc.M506466200. 9.Tsai, et al., Novel Cancer Therapeutics with Allosteric Modulation of the Mitochondrial C-Raf-DAPK Complex by Raf Inhibitor Combination Therapy. CancerResearch,2015.75(17):3568-3582.DOI: 10.1158/0008-5472.CAN-14-3264. 10.Balaban,et al., Mitochondria, oxidants, and aging. Cell, 2005. 120(4):483-495. DOI: 10.1016/j.cell.2005.02.001. 11.Benard, et al., Mitochondrial fusion and division: Regulation and role in cell viability. Seminars in Cell & Developmental Biology, 2009. 20(3):365-374. Doi:10.1016/j.semcdb.2008.12.012. 12.Ni, et al., Mitochondrial dynamics and mitochondrial quality control. Redox Biology, 2015. 4:6-13. DOI: 10.1016/j.redox.2014.11.006. 13.Persson, et al., A kinome-wide RNAi Screen in Drosophila Glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastoma. PLoS Genetics, 2013. 9(2):e1003253. DOI: 10.1371/journal.pgen.1003253. 14.Wang, et al., Analysis of mitochondrial structure and function in the Drosophila larval musculature. Mitochondrion, 2016. 26:33-42. DOI: 10.1016/j.mito.2015.11.005. 15.Wu, et al., DAPK activates MARK1/2 to regulate microtubule assembly, neuronal differentiation and tau toxicity. Cell Death & Differentiation, 2011. 18(9):1507-1520. DOI: 10.1038/cdd.2011.2. 16.Cohen, et al., DAP-kinase is a Ca2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. The EMBO Journal, 1997. 16(5):998-1008. DOI: 10.1093/emboj/16.5.998. 17.Lannutti, et al., Gprk2 controls cAMP levels in Drosophila development. Developmental Biology, 2001. 233(1):174-185. DOI: 10.1006/dbio.2001.0219. 18.Cheng, et al., Drosophila G-protein-coupled receptor kinase 2 regulates cAMP-dependent Hedgehog signaling. Development, 2012. 139(1):85-94. DOI: 10.1242/dev.068817. 19.Gambardella, et al., Dual role of GRK5 in cancer development and progression. Translational Medicine, 2016. 14:38-37. 20.Singh, et al., The novel tumour suppressor Madm regulates stem cell competition in the Drosophila testis. Nature Communications, 2016. 7:10473. DOI: 10.1038/ncomms10473. 21.Liao, et al., Nuclear receptor binding protein 1 correlates with better prognosis and induces caspase-dependent intrinsic apoptosis through the JNK signalling pathway in colorectal cancer. Cell Death & Disease, 2018. 9(4):436. DOI: 10.1038/s41419-018-0402-7. 22.Lu, et al., The Drosophila Pkn protein kinase is a Rho/Rac effector target required for dorsal closure during embryogenesis. Genes & Development, 1999. 13(9):1168-1180. DOI: 10.1101/gad.13.9.1168. 23.Schmidt, et al., Rho GTPases regulate PRK2/PKN2 to control entry. The EMBO Journal, 2007. 26(6):1624-1636. DOI: 10.1038/sj.emboj.7601637. 24.Cheng, et al., PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway. Molecular Cancer, 2018. 17(1):13. DOI: 10.1186/s12943-017-0747-z. 25.Brasier, Expanding role of cyclin dependent kinases in cytokine inducible gene expression. Cell Cycle, 2008. 7(17):2661-2666. DOI: 10.4161/cc.7.17.6594. 26.Wang, et al., Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology. Trends in Pharmacological Sciences, 2008. 29(6):302-313. DOI: 10.1016/j.tips.2008.03.003. 27.Franco, et al., CDK9: A key player in cancer and other diseases. Journal of Cellular Biochemistry, 2018. 119(2):1273-1284. DOI: 10.1002/jcb.26293. 28.Nakagawa, et al., ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Letters, 1996. 392(2):189-193. DOI: 10.1016/0014-5793(96)00811-3. 29.Sebbagh, et al., Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner. The Journal of Experimental Medicine, 2005. 201(3):465-471. DOI: 10.1084/jem.20031877. 30.Amano, et al., Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). The Journal of Biological Chemistry, 1996. 271(34):20246-20249. DOI: 10.1074/jbc.271.34.20246. 31.Stronach, et al., Activation of the JNK pathway during dorsal closure in Drosophila requires the mixed lineage kinase, slipper. Genes & Develoment, 2002. 16(3):377-387. DOI: 10.1101/gad.953002. 32.Tangredi, et al., The C-terminal kinase and ERK-binding domains of Drosophila S6KII (RSK) are required for phosphorylation of the protein and modulation of circadian behavior. Journal of Biological Chemistry, 2012. 287(20):16748-16758. DOI: 10.1074/jbc.M111.315929. 33.Geering, et al., Identification of novel death-associated protein kinase 2 interaction partners by proteomic screening coupled with bimolecular fluorescence complementation. Molecular and Cellular Biology, 2015. 36(1):132-143. DOI: 10.1128/MCB.00515-15. 34.Lee, et al., The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination to control interferon responses. The EMBO Journal, 2010. 29(10):1748-1761. DOI: 10.1038/emboj.2010.62. 35.Mebratu, et al., Bik reduces hyperplastic cells by increasing Bak and activating DAPk1 to juxtapose ER and mitochondria. Nature Communications, 2017. 8(1):803. DOI: 10.1038/s41467-017-00975-w.
|